Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1765-2017Class II

VITROS Immunodiagnostic Products NT-pro BNP Reagent Pack, REF/Catalog 680 2156, IVD --- Ortho-Clinical...

Ortho-Clinical Diagnostics, Inc. / initiated 2017-03-07 / Terminated / root cause: manufacturing process

ORTHO-CLINICAL DIAGNOSTICS began a recall of VITROS Immunodiagnostic Products NT-pro BNP Reagent Pack, REF/Catalog 680 2156, IVD --- Ortho-Clinical Diagnostics Pencoed, Bridgend CF35 5PZ, UK on . FDA classified it as Class II and gives the reason as "Increased frequency of calibration failures for VITROS Immunodiagnostic Products NT-proBNP Reagent Lots 1568, 1570, 1580 and 1590, due to background signals for these affected NT-proBNP lots that have been increasing...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1765-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ortho-Clinical Diagnostics, Inc.
Product
VITROS Immunodiagnostic Products NT-pro BNP Reagent Pack, REF/Catalog 680 2156, IVD --- Ortho-Clinical Diagnostics Pencoed, Bridgend CF35 5PZ, UK
Product code
NBC Test, Natriuretic Peptide
Reason for recall
Increased frequency of calibration failures for VITROS Immunodiagnostic Products NT-proBNP Reagent Lots 1568, 1570, 1580 and 1590, due to background signals for these affected NT-proBNP lots that have been increasing with time since release testing, resulting in higher than expected VITROS Immunodiagnostic Products NT-proBNP level 1 calibrator signals produced, leading to calibration failures.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 3/7/2017, IMPORTANT PRODUCT CORRECTION NOTIFICATION letter (Ref. CL2017-048) was sent via FedEx overnight courier and/ or ORTHO PLUS e-Communications and/ or US Postal Service Priority Mail (for PO Boxes only) to all customers and distributors who were shipped VITROS NT-proBNP Reagent Packs, Lots 1570, 1580 and/or 1590 to inform them of the issue and provided further instructions.
Quantity in commerce
US: 6324; Foreign: 1868
Distribution
Worldwide: United States, Puerto Rico, Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico, Panama, Poland, Singapore, Spain, and Venezuela.
Product codes and lots
Lot 1570 (expiry 22 March 2017),  Lot 1580 (expiry 13 April 2017),  Lot 1590 (expiry 27 April 2017)

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1765-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1765-2017Class IITerminatedVoluntary: Firm initiated